Virtus Fund Advisers LLC Makes New Investment in Phibro Animal Health Co. (NASDAQ:PAHC)

Virtus Fund Advisers LLC purchased a new stake in Phibro Animal Health Co. (NASDAQ:PAHC) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,263 shares of the company’s stock, valued at approximately $69,000.

A number of other hedge funds have also modified their holdings of PAHC. Barclays PLC increased its position in Phibro Animal Health by 25.7% during the third quarter. Barclays PLC now owns 143,337 shares of the company’s stock worth $3,228,000 after buying an additional 29,271 shares in the last quarter. SG Americas Securities LLC boosted its position in Phibro Animal Health by 7.4% during the fourth quarter. SG Americas Securities LLC now owns 13,162 shares of the company’s stock worth $276,000 after acquiring an additional 906 shares during the last quarter. Inspire Investing LLC purchased a new stake in Phibro Animal Health in the 4th quarter worth approximately $791,000. Smith Group Asset Management LLC purchased a new position in shares of Phibro Animal Health during the 4th quarter worth $541,000. Finally, New York State Teachers Retirement System boosted its holdings in shares of Phibro Animal Health by 16.7% during the fourth quarter. New York State Teachers Retirement System now owns 5,428 shares of the company’s stock worth $114,000 after purchasing an additional 775 shares during the last quarter. 99.34% of the stock is owned by hedge funds and other institutional investors.

Phibro Animal Health Price Performance

NASDAQ PAHC opened at $24.00 on Monday. The firm has a market capitalization of $972.82 million, a PE ratio of 50.00, a P/E/G ratio of 0.45 and a beta of 0.62. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37. Phibro Animal Health Co. has a 12 month low of $16.16 and a 12 month high of $26.55. The company’s 50 day simple moving average is $20.08 and its 200 day simple moving average is $21.85.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.63 EPS for the quarter, topping the consensus estimate of $0.52 by $0.11. The firm had revenue of $347.80 million for the quarter, compared to analysts’ expectations of $352.41 million. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. As a group, equities research analysts forecast that Phibro Animal Health Co. will post 1.95 EPS for the current fiscal year.

Phibro Animal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Wednesday, June 4th will be paid a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 2.00%. The ex-dividend date is Wednesday, June 4th. Phibro Animal Health’s dividend payout ratio is presently 61.54%.

Wall Street Analyst Weigh In

PAHC has been the topic of several research analyst reports. Morgan Stanley raised their target price on shares of Phibro Animal Health from $20.00 to $21.00 and gave the stock an “equal weight” rating in a research report on Thursday, May 8th. StockNews.com upgraded shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a research note on Friday, May 9th. Finally, Barclays lifted their price objective on Phibro Animal Health from $20.00 to $22.00 and gave the stock an “underweight” rating in a report on Monday, February 10th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $20.00.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.